Challenges and Recent Advances in Medulloblastoma Therapy.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  TIPS - Trends in Pharmacological Sciences

• Publication date

  2017-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.tips.2017.09.002PMID 29061299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intertumoral Heterogeneity within Medulloblastoma Subgroups.

  2017cited by this paper
• Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

  2017cited by this paper
• Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer

  2017cited by this paper
• Albumin nanoparticles for glutathione-responsive release of cisplatin: New opportunities for medulloblastoma.

  2017cited by this paper
• OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma.

  2017cited by this paper
• Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials

  2016cited by this paper
• Thymoquinone inhibits growth of human medulloblastoma cells by inducing oxidative stress and caspase-dependent apoptosis while suppressing NF-κB signaling and IL-8 expression

  2016cited by this paper
• Active medulloblastoma enhancers reveal subgroup-specific cellular origins

  2016cited by this paper
• Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.

  2016cited by this paper
• A Wireless Implantable Micropump for Chronic Drug Infusion Against Cancer.

  2016cited by this paper
• A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer

  2016cited by this paper
• Medulloblastoma stem cells: Promising targets in medulloblastoma therapy

  2016cited by this paper
• Design, synthesis and biological evaluation of 3-substituted indenoisoquinoline derivatives as topoisomerase I inhibitors.

  2016cited by this paper
• Expression levels of vascular endothelial cell growth factor and microRNA-210 are increased in medulloblastoma and metastatic medulloblastoma

  2015cited by this paper
• PEG-b-AGE Polymer Coated Magnetic Nanoparticle Probes with Facile Functionalization and Anti-fouling Properties for Reducing Non-specific Uptake and Improving Biomarker Targeting.

  2015cited by this paper
• Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.

  2015cited by this paper
• Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.

  2015cited by this paper
• IL-17 promoted the inhibition of medulloblastoma in mice by splenocyte injection

  2015cited by this paper
• Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis.

  2015cited by this paper
• Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

  2015cited by this paper
• EAG2 potassium channel with evolutionarily conserved function as a brain tumor target

  2015cited by this paper
• Genomic and Epigenetic Complexity of the FOXF1 Locus in 16q24.1: Implications for Development and Disease

  2015cited by this paper
• Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.

  2014cited by this paper
• Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence

  2014cited by this paper
• Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

  2014cited by this paper
• Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.

  2014cited by this paper
• Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma.

  2014cited by this paper
• Differences in vascular endothelial growth factor receptor expression and correlation with the degree of enhancement in medulloblastoma.

  2014cited by this paper
• Hedgehog Pathway Inhibition in Chondrosarcoma Using the Smoothened Inhibitor IPI-926 Directly Inhibits Sarcoma Cell Growth

  2014cited by this paper
• Recombinant anti‐podoplanin (NZ‐1) immunotoxin for the treatment of malignant brain tumors

  2013cited by this paper
• Intrathecal liposomal cytarabine and leptomeningeal medulloblastoma relapse: a valuable therapeutic option.

  2013cited by this paper
• Selective inhibition of tumor oncogenes by disruption of super-enhancers.

  2013cited by this paper
• Chemokines in tumor progression and metastasis

  2013cited by this paper
• Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma

  2013cited by this paper
• Master transcription factors and mediator establish super-enhancers at key cell identity genes.

  2013cited by this paper
• Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem

  2012cited by this paper
• Transcriptional amplification in tumor cells with elevated c-Myc.

  2012cited by this paper
• MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma

  2012cited by this paper
• Novel mutations target distinct subgroups of medulloblastoma

  2012cited by this paper
• MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS

  2012cited by this paper
• A mouse model of the most aggressive subgroup of human medulloblastoma.

  2012cited by this paper
• The association of statins plus LDL receptor‐targeted liposome‐encapsulated doxorubicin increases in vitro drug delivery across blood–brain barrier cells

  2012cited by this paper
• Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

  2012cited by this paper
• An animal model of MYC-driven medulloblastoma.

  2012cited by this paper
• Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas.

  2012cited by this paper
• Cytokine-induced cytokine production by conventional and innate lymphoid cells.

  2012cited by this paper
• Medulloblastomics: the end of the beginning

  2012cited by this paper
• Novel Agents Targeting the IGF-1R/PI3K Pathway Impair Cell Proliferation and Survival in Subsets of Medulloblastoma and Neuroblastoma

  2012cited by this paper
• CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma.

  2012cited by this paper
• A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.

  2011cited by this paper
• Medulloblastoma comprises four distinct molecular variants.

  2011cited by this paper
• Chemokines in health and disease.

  2011cited by this paper
• Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells.

  2011cited by this paper
• Molecular subgroups of medulloblastoma: the current consensus

  2011cited by this paper
• Regulation of interleukin-10 and interleukin-22 expression in T helper cells.

  2011cited by this paper
• Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma

  2011cited by this paper
• SPARC stimulates neuronal differentiation of medulloblastoma cells via the Notch1/STAT3 pathway.

  2011cited by this paper
• Identification and characterization of KCASH2 and KCASH3, 2 novel Cullin3 adaptors suppressing histone deacetylase and Hedgehog activity in medulloblastoma.

  2011cited by this paper
• Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells.

  2010cited by this paper
• Second generation 2-pyridyl biphenyl amide inhibitors of the hedgehog pathway.

  2010cited by this paper
• Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

  2010cited by this paper
• Histone deacetylase and Cullin3–RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation

  2010cited by this paper
• Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas.

  2010cited by this paper
• Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells.

  2010cited by this paper
• Members of the low‐density lipoprotein receptor‐related proteins provide a differential molecular signature between parental and CD133(+) DAOY medulloblastoma cells

  2010cited by this paper
• Interleukin and Interleukin Receptor Diversity: Role of Alternative Splicing

  2010cited by this paper
• The Role of T-Helper 17 (Th17) Cells in Patients with Medulloblastoma

  2010cited by this paper
• Subtypes of medulloblastoma have distinct developmental origins

  2010cited by this paper
• An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growth.

  2010cited by this paper
• MicroRNA 128a Increases Intracellular ROS Level by Targeting Bmi-1 and Inhibits Medulloblastoma Cancer Cell Growth by Promoting Senescence

  2010cited by this paper
• Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.

  2009cited by this paper
• Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth

  2009cited by this paper
• The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials

  2009cited by this paper
• Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).

  2009cited by this paper
• A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells.

  2009cited by this paper
• The miR-17∼92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma

  2009cited by this paper
• Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade

  2009cited by this paper
• Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor

  2009cited by this paper
• miR-124 regulates adult neurogenesis in the SVZ stem cell niche

  2009cited by this paper
• Deletion of Atoh1 Disrupts Sonic Hedgehog Signaling in the Developing Cerebellum and Prevents Medulloblastoma

  2009cited by this paper
• Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.

  2008cited by this paper
• Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma.

  2008cited by this paper
• Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells

  2008cited by this paper
• The origins of medulloblastoma subtypes.

  2008cited by this paper
• Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma

  2008cited by this paper
• Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.

  2008cited by this paper
• Histologic Features and Prognosis in Pediatric Medulloblastoma

  2008cited by this paper
• miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

  2008cited by this paper
• An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.

  2008cited by this paper
• Hedgehog: functions and mechanisms.

  2008cited by this paper
• Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

  2008cited by this paper
• Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists

  2007cited by this paper
• Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis.

  2007cited by this paper
• The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.

  2007cited by this paper
• Medulloblastomas derived from Cxcr6 mutant mice respond to treatment with a smoothened inhibitor.

  2007cited by this paper
• Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance.

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Medulloblastoma in childhood: new biological advances.

  2007cited by this paper
• Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors.

  2006cited by this paper
• Reciprocal actions of REST and a microRNA promote neuronal identity

  2006cited by this paper

• Does the B7-H3 Immune Checkpoint Have High Potential as a Therapeutic Target?

  2026cites this paper
• Orphan G protein-coupled receptor GPR137 regulates ferroptosis by targeting the Wnt/β-catenin pathway in sonic hedgehog-medulloblastoma

  2026cites this paper
• Advancing Medulloblastoma Therapy in Pediatrics: Integrative Molecular Classification and Emerging Treatments

  2025cites this paper
• Tryptamine-Functionalized Lipid Nanocarriers Co-delivering SMO/BRD4 Inhibitors for Synergistic Medulloblastoma Therapy

  2025cites this paper
• COG133 peptide-conjugated lipid nanoparticles sensitize medulloblastoma to radiation therapy in mice.

  2025cites this paper
• Overcoming Treatment Resistance in Medulloblastoma: Underlying Mechanisms and Potential Strategies

  2024influential citation
• GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma

  2024cites this paper
• PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor

  2024cites this paper
• Machine Learning-Driven Identification of Molecular Subgroups in Medulloblastoma via Gene Expression Profiling

  2024cites this paper
• miR-30b-5p Promotes Medulloblastoma Cell Proliferation by Regulating Stem Cell Factors NANOG, BMI1, Tumor Suppressor Gene P53 and the Shh-Gli1 Pathway

  2024cites this paper
• Cascade catalyzed dual-responsive Gold-Ferri “bomb-like” nanoreactors for positive feedback penetrating in sequential targeted triple glioblastoma therapy

  2024cites this paper
• Intracerebellar administration of the chemokine Cxcl3 reduces the volume of medulloblastoma lesions at an advanced stage by promoting the migration and differentiation of preneoplastic precursor cells

  2024cites this paper
• Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model

  2023influential citation
• Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance

  2023cites this paper
• Hedgehog signaling in tissue homeostasis, cancers and targeted therapies

  2023cites this paper
• Surviving the Hunger Games: Metabolic Reprogramming in Medulloblastoma

  2023cites this paper
• Prognostic Significance of MicroRNAs in Medulloblastoma: A Systematic Review and Meta-Analysis

  2023cites this paper
• Effectiveness of metronomic chemotherapy in a child with medulloblastoma: A case report

  2023cites this paper
• Integrin-αVβ3 is a fundamental factor in medulloblastoma tumorigenicity and radioresistance: A new game for an old player

  2023cites this paper
• Pharmacophore-Aided Virtual Screening and Molecular Dynamics Simulation Identifies TrkB Agonists for Treatment of CDKL5-Deficiency Disorders

  2023cites this paper
• Research progress in molecular pathology markers in medulloblastoma

  2023cites this paper
• Targeting BRD4 and PI3K signaling pathways for the treatment of medulloblastoma.

  2023cites this paper
• Protocols to Manufacture an Oncolytic Measles Virus-Sensitive Immunocompetent Mouse Model of Medulloblastoma.

  2022cites this paper
• Identification of potential crucial genes and mechanisms associated with metastasis of medulloblastoma based on gene expression profile

  2022cites this paper
• Recent advances in drug delivery and targeting to the brain.

  2022cites this paper
• Challenges and Recent Advances of Novel Chemical Inhibitors in Medulloblastoma Therapy.

  2022cites this paper
• Prognostic Value of miR-137 in Children with Medulloblastoma and its Regulatory Effect on Tumor Progression

  2021cites this paper
• Medulloblastoma drugs in development: Current leads, trials and drawbacks.

  2021cites this paper
• Inter and intra-tumoral heterogeneity as a platform for personalized therapies in medulloblastoma.

  2021cites this paper
• Novel Molecular Hallmarks of Group 3 Medulloblastoma by Single-Cell Transcriptomics

  2021cites this paper
• Synergistische Wirkung des BRD4-Inhibitors MK-8628 und PLK1-Inhibitors Volasertib in vorklinischen Modellen des Medulloblastoms

  2021influential citation
• Epigenetic-Based Therapy—A Prospective Chance for Medulloblastoma Patients’ Recovery

  2021cites this paper
• Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies

  2021cites this paper
• Stem-Like Cell Populations, p53-Pathway Activation and Mechanisms of Recurrence in Sonic Hedgehog Medulloblastoma

  2021cites this paper
• Reducing false positive prediction of miRNA target genes with RNA sequencing: Hype or hope

  2021cites this paper
• Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma.

  2021cites this paper
• MAPK15 Controls Hedgehog Signaling in Medulloblastoma Cells by Regulating Primary Ciliogenesis

  2021cites this paper
• Brain Cancer Drug Discovery: Clinical Trials, Drug Classes, Targets, and Combinatorial Therapies

  2021cites this paper
• Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives

  2021cites this paper
• Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups

  2021influential citation
• Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma

  2021cites this paper
• Deficiency in the Treatment Description of mTOR Inhibitor Resistance in Medulloblastoma, a Systematic Review

  2021influential citation
• Production of a SCID mouse model of medulloblastoma to explore the therapeutic value of targeting tumor driver genes

  2020cites this paper
• Exosomal miR-130b-3p targets SIK1 to inhibit medulloblastoma tumorigenesis

  2020cites this paper
• ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice.

  2020cites this paper
• Erbb4 Is Required for Cerebellar Development and Malignant Phenotype of Medulloblastoma

  2020cites this paper
• Heterozygous mutation of Sonic Hedgehog receptor (Ptch) drives cerebellar overgrowth and sex-specifically alters hippocampal and cortical layer structure, activity, and social behavior in female mice

  2020cites this paper
• Medulloblastoma cancer stem cells: molecular signatures and therapeutic targets

  2020cites this paper
• MicroRNA‐31 weakens cisplatin resistance of medulloblastoma cells via NF‐κB and PI3K/AKT pathways

  2020cites this paper
• Ecdysteroid Derivatives that Reverse P-Glycoprotein-Mediated Drug Resistance

  2020cites this paper
• “The anti-angiogenic compound axitinib demonstrates low toxicity and anti-tumoral effects against medulloblastoma”

  2020cites this paper
• Inhibition of Long Noncoding RNA CRNDE Increases Chemosensitivity of Medulloblastoma Cells by Targeting miR-29c-3p

  2019cites this paper
• miR-489 promotes apoptosis and inhibits invasiveness of glioma cells by targeting PAK5/RAF1 signaling pathways

  2019cites this paper
• Dodging the bullet: therapeutic resistance mechanisms in pediatric cancers

  2019cites this paper
• Human Sialic acid O-acetyl esterase ( SIAE ) – mediated changes in sensitivity to etoposide in a medulloblastoma cell line Journal Item

  2019cites this paper
• Human Sialic acid O-acetyl esterase (SIAE) – mediated changes in sensitivity to etoposide in a medulloblastoma cell line

  2019cites this paper
• OTT_A_228305 9873..9885

  2019cites this paper
• Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma

  2019cites this paper
• Long Noncoding RNA TP73-AS1 Modulates Medulloblastoma Progression In Vitro And In Vivo By Sponging miR-494-3p And Targeting EIF5A2

  2019cites this paper
• Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma

  2019influential citation
• Identification of Hub Genes in Pediatric Medulloblastoma by Multiple-Microarray Analysis

  2019cites this paper
• Specification of Granule Cells and Purkinje Cells

  2019cites this paper
• Impact of miRNA-mRNA Profiling and Their Correlation on Medulloblastoma Tumorigenesis

  2018influential citation
• Medulloblastoma

  2018influential citation
• 68Ga-DOTANOC PET/CT in Medulloblastoma.

  2018cites this paper
• Duality of estrogen receptor &bgr; action in cancer progression

  2018cites this paper
• Pharmacological inhibition of the amino-acid transporter LAT1 demonstrates in vitro anti-neoplastic activity towards medulloblastoma

  2018cites this paper
• Targeting mTOR as a Therapeutic Approach in Medulloblastoma

  2018influential citation
• Medulloblastoma: Challenges and advances in treatment and research

  2018cites this paper
• Oxamate, but Not Selective Targeting of LDH-A, Inhibits Medulloblastoma Cell Glycolysis, Growth and Motility

  2018cites this paper
• Childhood Medulloblastoma Revisited

  2018cites this paper
• Low Expression of miR-466f-3p Sustains Epithelial to Mesenchymal Transition in Sonic Hedgehog Medulloblastoma Stem Cells Through Vegfa-Nrp2 Signaling Pathway

  2018cites this paper
• The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer

  2018cites this paper
• An oncolytic measles virus–sensitive Group 3 medulloblastoma model in immune-competent mice

  2017cites this paper